• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CCL25/CCR9信号促进肝癌和乳腺癌细胞系的迁移与侵袭。

CCL25/CCR9 Signal Promotes Migration and Invasion in Hepatocellular and Breast Cancer Cell Lines.

作者信息

Zhang Ziqi, Sun Tong, Chen Yuxi, Gong Shu, Sun Xiye, Zou Fangdong, Peng Rui

机构信息

1 West China School of Medicine, Sichuan University , Chengdu, People's Republic of China .

2 Key Laboratory of Bio-Resources and Eco-Environment (Ministry of Education), College of Life Sciences, Sichuan University , Chengdu, People's Republic of China .

出版信息

DNA Cell Biol. 2016 Jul;35(7):348-57. doi: 10.1089/dna.2015.3104. Epub 2016 Mar 23.

DOI:10.1089/dna.2015.3104
PMID:27008282
Abstract

Cancer is one of the most lethal diseases worldwide, and metastasis is the most common cause of patients' deaths. Identification and inhibition of markers involved in metastasis process in cancer cells are promising works to block metastasis and improve prognoses of patients. Chemokines are a superfamily of small, chemotactic cytokines, whose functions are based on interaction with corresponding receptors. It has been found that one of the functions of chemokines is to regulate migration and invasion abilities of lymphocytes, as well as cancer cells. Chemokine receptor 9 (CCR9) regulates trafficking of lymphocytes and cancer cell lines when interacting with its exclusive ligand chemokine 25 (CCL25). However, the mechanisms of CCL25/CCR9 signal that regulates metastasis of cancer cells are not completely known yet. In this study, we stimulated or inhibited CCL25/CCR9 signal in breast cancer cell line (MDA-MB-231) and hepatocellular cancer cell lines (HepG2 and HUH7), and found that CCL25/CCR9 signal resulted in different promotion of migration and invasion in different cell lines. These phenomena could be explained by selective regulation of several markers of epithelial-mesenchymal transition (EMT). Our findings suggested that CCL25/CCR9 signal may provide cancer cells with chemotactic abilities through influencing several EMT markers.

摘要

癌症是全球最致命的疾病之一,而转移是患者死亡的最常见原因。识别和抑制癌细胞转移过程中涉及的标志物是阻断转移并改善患者预后的有前景的工作。趋化因子是一类小的趋化细胞因子超家族,其功能基于与相应受体的相互作用。已发现趋化因子的功能之一是调节淋巴细胞以及癌细胞的迁移和侵袭能力。趋化因子受体9(CCR9)在与其唯一配体趋化因子25(CCL25)相互作用时调节淋巴细胞和癌细胞系的运输。然而,CCL25/CCR9信号调节癌细胞转移的机制尚未完全清楚。在本研究中,我们在乳腺癌细胞系(MDA-MB-231)和肝癌细胞系(HepG2和HUH7)中刺激或抑制CCL25/CCR9信号,发现CCL25/CCR9信号在不同细胞系中对迁移和侵袭有不同的促进作用。这些现象可以通过上皮-间质转化(EMT)的几种标志物的选择性调节来解释。我们的研究结果表明,CCL25/CCR9信号可能通过影响几种EMT标志物为癌细胞提供趋化能力。

相似文献

1
CCL25/CCR9 Signal Promotes Migration and Invasion in Hepatocellular and Breast Cancer Cell Lines.CCL25/CCR9信号促进肝癌和乳腺癌细胞系的迁移与侵袭。
DNA Cell Biol. 2016 Jul;35(7):348-57. doi: 10.1089/dna.2015.3104. Epub 2016 Mar 23.
2
CCR9 and CCL25: A review of their roles in tumor promotion.CCR9 和 CCL25:在肿瘤促进中的作用综述。
J Cell Physiol. 2020 Dec;235(12):9121-9132. doi: 10.1002/jcp.29782. Epub 2020 May 13.
3
CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.CCL25-CCR9 相互作用调节卵巢癌细胞迁移、金属蛋白酶表达和侵袭。
World J Surg Oncol. 2010 Jul 22;8:62. doi: 10.1186/1477-7819-8-62.
4
CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion.CCL25 通过 CCR9 依赖性方式介导乳腺癌细胞的迁移、侵袭和基质金属蛋白酶表达。
Int J Oncol. 2011 May;38(5):1279-85. doi: 10.3892/ijo.2011.953. Epub 2011 Feb 23.
5
Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.CCR9 和 CCL25 在卵巢癌中的表达及与组织病理学的相关性。
Int J Oncol. 2011 Aug;39(2):373-81. doi: 10.3892/ijo.2011.1059. Epub 2011 May 31.
6
Expression and functional role of CCR9 in prostate cancer cell migration and invasion.CCR9在前列腺癌细胞迁移和侵袭中的表达及功能作用
Clin Cancer Res. 2004 Dec 15;10(24):8743-50. doi: 10.1158/1078-0432.CCR-04-0266.
7
CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.CCR9 介导前列腺癌细胞中 PI3K/AKT 依赖性抗凋亡信号,抑制 CCR9-CCL25 相互作用增强依托泊苷的细胞毒性作用。
Int J Cancer. 2010 Nov 1;127(9):2020-30. doi: 10.1002/ijc.25219.
8
CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway.CCR9与CCL25的相互作用通过激活PI3K/Akt信号通路抑制肺癌细胞凋亡。
Med Oncol. 2015 Mar;32(3):66. doi: 10.1007/s12032-015-0531-0. Epub 2015 Feb 18.
9
CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion.CCR9-CCL25 相互作用通过 Akt 的激活促进乳腺癌细胞对顺铂的耐药性,这种激活是依赖于 PI3K 且不依赖于 FAK 的方式。
World J Surg Oncol. 2011 May 3;9:46. doi: 10.1186/1477-7819-9-46.
10
Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis.趋化因子 25 诱导的信号抑制结肠癌细胞侵袭和转移。
J Clin Invest. 2012 Sep;122(9):3184-96. doi: 10.1172/JCI62110. Epub 2012 Aug 6.

引用本文的文献

1
Dual roles of innate immune cells and cytokines in shaping the breast cancer microenvironment.天然免疫细胞和细胞因子在塑造乳腺癌微环境中的双重作用。
Front Immunol. 2025 Aug 20;16:1654947. doi: 10.3389/fimmu.2025.1654947. eCollection 2025.
2
CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia.靶向CCR9和CD1a的嵌合抗原受体T细胞用于治疗T细胞急性淋巴细胞白血病。
J Hematol Oncol. 2025 Jul 1;18(1):69. doi: 10.1186/s13045-025-01715-0.
3
Cytokines and oral cancer risk: Genetic evidence from a bidirectional Mendelian randomization study.
细胞因子与口腔癌风险:一项双向孟德尔随机化研究的遗传学证据
Medicine (Baltimore). 2025 Jun 6;104(23):e42642. doi: 10.1097/MD.0000000000042642.
4
Genetic variants of , , and in the T cell exhaustion-related genes are associated with non-small cell lung cancer survival.T 细胞耗竭相关基因中的 、 和 遗传变异与非小细胞肺癌的生存相关。
Front Immunol. 2024 Oct 2;15:1455927. doi: 10.3389/fimmu.2024.1455927. eCollection 2024.
5
Circ_0000069 promotes the development of hepatocellular carcinoma by regulating CCL25.环状 RNA 0000069 通过调节 CCL25 促进肝细胞癌的发展。
BMC Cancer. 2024 Jul 11;24(1):827. doi: 10.1186/s12885-024-12594-y.
6
PCSK9 promotes tumor cell proliferation and migration by facilitating CCL25 secretion in esophageal squamous cell carcinoma.在食管鳞状细胞癌中,前蛋白转化酶枯草溶菌素9(PCSK9)通过促进趋化因子配体25(CCL25)的分泌来促进肿瘤细胞增殖和迁移。
Oncol Lett. 2023 Oct 4;26(5):500. doi: 10.3892/ol.2023.14086. eCollection 2023 Nov.
7
Determination of the Binding Epitope of an Anti-Mouse CCR9 Monoclonal Antibody (CMab-24) Using the 1× Alanine and 2× Alanine-Substitution Method.使用单丙氨酸和双丙氨酸取代法确定抗小鼠CCR9单克隆抗体(CMab-24)的结合表位
Antibodies (Basel). 2023 Jan 31;12(1):11. doi: 10.3390/antib12010011.
8
Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9 tumors.抗 CCR9 mAb 的治疗潜力在人 CCR9 肿瘤的异种移植物中得到证实。
Front Immunol. 2022 Jul 27;13:825635. doi: 10.3389/fimmu.2022.825635. eCollection 2022.
9
Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer.趋化因子-粘蛋白组在塑造胰腺癌异质性肿瘤微环境中的相互作用。
Semin Cancer Biol. 2022 Nov;86(Pt 2):511-520. doi: 10.1016/j.semcancer.2022.03.022. Epub 2022 Mar 26.
10
Identification of hub genes in gastric cancer by integrated bioinformatics analysis.通过综合生物信息学分析鉴定胃癌中的枢纽基因
Transl Cancer Res. 2021 Jun;10(6):2831-2840. doi: 10.21037/tcr-20-3540.